Lola Rodríguez Nogueira, Rodrigo España, María Ruiz Vico, Jorge Esteban Villarrubia, Casilda Llacer, Rebeca Lozano, Nuria Romero-Laorden, Guillermo de Velasco, Rosa Villatoro, Lucía García, Pablo Alvarez-Ballesteros, David Hernandez, Alfredo Rodríguez Antolín, Enrique González-Billalabeitia, Bernardo Herrera Imbroda, Daniel Castellano, Elena Castro, David Lorente, David Olmos. "A novel prognostic model to optimize the timing of docetaxel (Doc) following an androgen receptor pathway inhibitor (ARPi) in metastasic castration-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5063